Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

Clinical trial NCT00260689 · COMPLETED

Trial details

NCT number: NCT00260689
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Immunosuppresion Thrombocytopenia Pancytopenia Neutropenia

Start date: 2005-11-28
Primary completion: 2016-05-04
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.